Literature DB >> 1955469

Intracellular transport and localization of major histocompatibility complex class II molecules and associated invariant chain.

J Pieters1, H Horstmann, O Bakke, G Griffiths, J Lipp.   

Abstract

The intracellular transport and location of major histocompatibility complex (MHC) class II molecules and associated invariant chain (Ii) were investigated in a human melanoma cell line. In contrast to the class II molecules, which remain stable for greater than 4 h after synthesis, the associated Ii is proteolytically processed within 2 h. During or shortly after synthesis the NH2-terminal cytoplasmic and membrane-spanning segment is in some of the Ii molecules cleaved off; during intracellular transport, class II associated and membrane integrated Ii is processed from its COOH terminus in distinct steps in endocytic compartments. Immunocytochemical studies at the light and electron microscopic level revealed the presence of class II molecules, but not of Ii on the cell surface. Intracellularly both Ii and class II molecules were localized in three morphologically and kinetically distinct compartments, early endosomes, multivesicular bodies, and prelysosomes. This localization in several distinct endosomal compartments contrasts with the localization of class II molecules in mainly one endocytic compartment in B lymphoblastoid cell lines. As in these lymphoblastoid cell lines Ii is known to be rapidly degraded it is conceivable that the rate of proteolysis of the class II associated Ii and its dissociation from class II molecules modulates the retention of the oligomeric complex in endocytic compartments, and as a consequence the steady-state distribution of these molecules within the endosomal system.

Entities:  

Mesh:

Year:  1991        PMID: 1955469      PMCID: PMC2289241          DOI: 10.1083/jcb.115.5.1213

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  45 in total

Review 1.  MHC class II invariant chains in antigen processing and presentation.

Authors:  N Koch; J Lipp; U Pessara; K Schenck; C Wraight; B Dobberstein
Journal:  Trends Biochem Sci       Date:  1989-09       Impact factor: 13.807

Review 2.  Co-localization of molecules involved in antigen processing and presentation in an early endocytic compartment.

Authors:  L E Guagliardi; B Koppelman; J S Blum; M S Marks; P Cresswell; F M Brodsky
Journal:  Nature       Date:  1990-01-11       Impact factor: 49.962

Review 3.  The biogenesis of lysosomes.

Authors:  S Kornfeld; I Mellman
Journal:  Annu Rev Cell Biol       Date:  1989

4.  Successful clinical use of an anti-HLA-DR monoclonal antibody for autologous bone marrow transplantation.

Authors:  G Kvalheim; S Funderud; S Kvaløy; G Gaudernack; K Beiske; E Jakobsen; A B Jacobsen; A Pihl; O Fodstad
Journal:  J Natl Cancer Inst       Date:  1988-10-19       Impact factor: 13.506

5.  Time course of intracellular associations, processing, and cleavages of Ii forms and class II major histocompatibility complex molecules.

Authors:  Q V Nguyen; R E Humphreys
Journal:  J Biol Chem       Date:  1989-01-25       Impact factor: 5.157

Review 6.  Intracellular traffic and antigen processing.

Authors:  E O Long
Journal:  Immunol Today       Date:  1989-07

7.  Cleavage of parathyroid hormone in macrophage endosomes illustrates a novel pathway for intracellular processing of proteins.

Authors:  S Diment; K J Martin; P D Stahl
Journal:  J Biol Chem       Date:  1989-08-15       Impact factor: 5.157

8.  The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route.

Authors:  J J Neefjes; V Stollorz; P J Peters; H J Geuze; H L Ploegh
Journal:  Cell       Date:  1990-04-06       Impact factor: 41.582

9.  Characterization of the early endosome and putative endocytic carrier vesicles in vivo and with an assay of vesicle fusion in vitro.

Authors:  J Gruenberg; G Griffiths; K E Howell
Journal:  J Cell Biol       Date:  1989-04       Impact factor: 10.539

10.  Meeting of the apical and basolateral endocytic pathways of the Madin-Darby canine kidney cell in late endosomes.

Authors:  R G Parton; K Prydz; M Bomsel; K Simons; G Griffiths
Journal:  J Cell Biol       Date:  1989-12       Impact factor: 10.539

View more
  36 in total

1.  Early endosomes are required for major histocompatiblity complex class II transport to peptide-loading compartments.

Authors:  V Brachet; G Péhau-Arnaudet; C Desaymard; G Raposo; S Amigorena
Journal:  Mol Biol Cell       Date:  1999-09       Impact factor: 4.138

2.  Involvement of clathrin and AP-2 in the trafficking of MHC class II molecules to antigen-processing compartments.

Authors:  Peter J McCormick; José A Martina; Juan S Bonifacino
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-23       Impact factor: 11.205

3.  Costimulatory ligand CD70 is delivered to the immunological synapse by shared intracellular trafficking with MHC class II molecules.

Authors:  Anna M Keller; Tom A Groothuis; Elise A M Veraar; Marije Marsman; Lucas Maillette de Buy Wenniger; Hans Janssen; Jacques Neefjes; Jannie Borst
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-26       Impact factor: 11.205

Review 4.  MHC class II antigen presentation by dendritic cells regulated through endosomal sorting.

Authors:  Toine ten Broeke; Richard Wubbolts; Willem Stoorvogel
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-12-01       Impact factor: 10.005

5.  Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation.

Authors:  G Raposo; D Tenza; S Mecheri; R Peronet; C Bonnerot; C Desaymard
Journal:  Mol Biol Cell       Date:  1997-12       Impact factor: 4.138

6.  Functionality of major histocompatibility complex class II molecules in mice doubly deficient for invariant chain and H-2M complexes.

Authors:  S Tourne; T Miyazaki; P Wolf; H Ploegh; C Benoist; D Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

7.  Small amounts of sub-visible aggregates enhance the immunogenic potential of monoclonal antibody therapeutics.

Authors:  Maryam Ahmadi; Christine J Bryson; Edward A Cloake; Katie Welch; Vasco Filipe; Stefan Romeijn; Andrea Hawe; Wim Jiskoot; Matthew P Baker; Mark H Fogg
Journal:  Pharm Res       Date:  2015-04       Impact factor: 4.200

8.  Cell surface expression and metabolism of major histocompatibility complex class II invariant chain (CD74) by diverse cell lines.

Authors:  G L Ong; D M Goldenberg; H J Hansen; M J Mattes
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

Review 9.  Endosomal localization of MHC class II-invariant chain complexes.

Authors:  J Miller
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

10.  Proteolysis of major histocompatibility complex class II-associated invariant chain is regulated by the alternatively spliced gene product, p41.

Authors:  B Fineschi; L S Arneson; M F Naujokas; J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.